Ion Beam Applications SA

ENXTBR:IBAB Rapport sur les actions

Capitalisation boursière : €391.0m

Ion Beam Applications Résultats passés

Passé contrôle des critères 2/6

Ion Beam Applications's earnings have been declining at an average annual rate of -32.3%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 9.3% per year. Ion Beam Applications's return on equity is 8.7%, and it has net margins of 1.7%.

Informations clés

-32.3%

Taux de croissance des bénéfices

-32.3%

Taux de croissance du BPA

Medical Equipment Croissance de l'industrie12.3%
Taux de croissance des recettes9.3%
Rendement des fonds propres8.7%
Marge nette1.7%
Prochaine mise à jour des résultats21 Nov 2024

Mises à jour récentes des performances passées

Recent updates

Ion Beam Applications SA (EBR:IBAB) Shares Fly 25% But Investors Aren't Buying For Growth

Oct 08
Ion Beam Applications SA (EBR:IBAB) Shares Fly 25% But Investors Aren't Buying For Growth

Is Now An Opportune Moment To Examine Ion Beam Applications SA (EBR:IBAB)?

Sep 19
Is Now An Opportune Moment To Examine Ion Beam Applications SA (EBR:IBAB)?

It's Unlikely That The CEO Of Ion Beam Applications SA (EBR:IBAB) Will See A Huge Pay Rise This Year

Jun 06
It's Unlikely That The CEO Of Ion Beam Applications SA (EBR:IBAB) Will See A Huge Pay Rise This Year

Further Upside For Ion Beam Applications SA (EBR:IBAB) Shares Could Introduce Price Risks After 29% Bounce

Mar 25
Further Upside For Ion Beam Applications SA (EBR:IBAB) Shares Could Introduce Price Risks After 29% Bounce

Is Ion Beam Applications (EBR:IBAB) Using Too Much Debt?

Nov 07
Is Ion Beam Applications (EBR:IBAB) Using Too Much Debt?

Ion Beam Applications (EBR:IBAB) Has Some Way To Go To Become A Multi-Bagger

Oct 05
Ion Beam Applications (EBR:IBAB) Has Some Way To Go To Become A Multi-Bagger

Ion Beam Applications (EBR:IBAB) Is Investing Its Capital With Increasing Efficiency

Jan 31
Ion Beam Applications (EBR:IBAB) Is Investing Its Capital With Increasing Efficiency

Is Ion Beam Applications (EBR:IBAB) A Risky Investment?

Sep 28
Is Ion Beam Applications (EBR:IBAB) A Risky Investment?

Here's Why Shareholders May Want To Be Cautious With Increasing Ion Beam Applications SA's (EBR:IBAB) CEO Pay Packet

Jun 01
Here's Why Shareholders May Want To Be Cautious With Increasing Ion Beam Applications SA's (EBR:IBAB) CEO Pay Packet

Ion Beam Applications' (EBR:IBAB) Returns On Capital Are Heading Higher

May 29
Ion Beam Applications' (EBR:IBAB) Returns On Capital Are Heading Higher

Does Ion Beam Applications SA (EBR:IBAB) Have A Place In Your Dividend Stock Portfolio?

Apr 20
Does Ion Beam Applications SA (EBR:IBAB) Have A Place In Your Dividend Stock Portfolio?

Is Ion Beam Applications (EBR:IBAB) A Risky Investment?

Mar 30
Is Ion Beam Applications (EBR:IBAB) A Risky Investment?

Should You Use Ion Beam Applications' (EBR:IBAB) Statutory Earnings To Analyse It?

Feb 10
Should You Use Ion Beam Applications' (EBR:IBAB) Statutory Earnings To Analyse It?

What Type Of Shareholders Make Up Ion Beam Applications SA's (EBR:IBAB) Share Registry?

Jan 06
What Type Of Shareholders Make Up Ion Beam Applications SA's (EBR:IBAB) Share Registry?

Does This Valuation Of Ion Beam Applications SA (EBR:IBAB) Imply Investors Are Overpaying?

Dec 10
Does This Valuation Of Ion Beam Applications SA (EBR:IBAB) Imply Investors Are Overpaying?

Ion Beam Applications' (EBR:IBAB) Shareholders Are Down 64% On Their Shares

Nov 17
Ion Beam Applications' (EBR:IBAB) Shareholders Are Down 64% On Their Shares

Ion Beam Applications SA (EBR:IBAB) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Aug 20
Ion Beam Applications SA (EBR:IBAB) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Estimating The Intrinsic Value Of Ion Beam Applications SA (EBR:IBAB)

Jul 21
Estimating The Intrinsic Value Of Ion Beam Applications SA (EBR:IBAB)

Ventilation des recettes et des dépenses

Comment Ion Beam Applications gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

ENXTBR:IBAB Recettes, dépenses et bénéfices (EUR Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 2446688251
31 Mar 24447-18149
31 Dec 23429-98048
30 Sep 23400-147847
30 Jun 23371-197746
31 Mar 23366-77544
31 Dec 2236167442
30 Sep 2234957140
30 Jun 2233646939
31 Mar 2232446536
31 Dec 2131346034
30 Sep 21326236133
30 Jun 21339426133
31 Mar 21326376133
31 Dec 20312326133
30 Sep 20288166132
30 Jun 2026416131
31 Mar 2027346231
31 Dec 1928386231
30 Sep 1932557438
30 Jun 19295-26734
31 Mar 19276-36431
01 Jan 19257-46128
30 Sep 18229-255826
30 Jun 18175-454521
31 Mar 18206-435124
31 Dec 17236-425727
30 Sep 17311-147334
30 Jun 17335127333
31 Mar 17332187133
31 Dec 16329257032
30 Sep 16312406731
30 Jun 16294556430
31 Mar 16282586128
01 Jan 16270615827
01 Oct 15257465627
30 Jun 15243315427
31 Mar 15232265325
31 Dec 14221215123
30 Sep 1421794923
30 Jun 14213-24923
31 Mar 14213-34823
31 Dec 13213-44823

Des revenus de qualité: IBAB has a large one-off loss of €4.4M impacting its last 12 months of financial results to 30th June, 2024.

Augmentation de la marge bénéficiaire: IBAB became profitable in the past.


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: IBAB has become profitable over the past 5 years, growing earnings by -32.3% per year.

Accélération de la croissance: IBAB has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Bénéfices par rapport au secteur d'activité: IBAB has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.7%).


Rendement des fonds propres

ROE élevé: IBAB's Return on Equity (8.7%) is considered low.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé